Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with Merck SOUTH SAN FRANCISCO, Calif., July 26, 2022 – Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage oncology company pioneering...
Sutro Biopharma
310 Utah Ave
Suite 150
South San Francisco, CA 94080
650.392.8412